Skip to content

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$1.5B+11.4%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$1.39B+86.6%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$1.46B+205%
Biohaven logo
BiohavenBHVN
$466.41M+1.6%
Septerna, Inc. logo
Septerna, Inc.SEPN
$569.69M+31.3%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$24.2M+10.7%
Net income-$19.9M+17.5%
EPS (diluted)-$0.42+38.2%

Balance sheet

See full
Cash & equivalents$78.1M+35.5%
Total debt$10.8M+37.8%
Total equity$471.5M+65.0%

Cash flow

See full
Operating cash flow-$13.1M+35.5%
CapEx$86.0K-70.4%
Free cash flow-$13.1M+36.0%

Valuation

See full
Market cap$1.86B+309%
Enterprise value$1.79B+352%

Returns & leverage

See full
Return on equity-28.3%
Debt / equity0.0×
Current ratio27.1×-3.9×

Where this comes from

Reported directly by Rapport Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s total assets?
Rapport Therapeutics, Inc. (RAPP) reported total assets of $497.6M in Q1 2026.
How has Rapport Therapeutics, Inc.'s total assets changed year-over-year?
Rapport Therapeutics, Inc.'s total assets increased by 64.7% year-over-year, from $302.05M to $497.6M.
What is the long-term trend for Rapport Therapeutics, Inc.'s total assets?
Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s total assets has grown at a 81.6% compound annual growth rate (CAGR), from $155.42M to $512.43M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.